Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Sagimet Biosciences (SGMT) EPS (Weighted Average and Diluted) (2023 - 2024)

Sagimet Biosciences (SGMT) has 2 years of EPS (Weighted Average and Diluted) data on record, last reported at -$0.5 in Q4 2024.

  • For Q4 2024, EPS (Weighted Average and Diluted) fell 189.29% year-over-year to -$0.5; the TTM value through Dec 2024 reached -$1.43, up 97.99%, while the annual FY2025 figure was -$1.58, 8.97% down from the prior year.
  • EPS (Weighted Average and Diluted) reached -$0.5 in Q4 2024 per SGMT's latest filing, down from -$0.45 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.56 in Q4 2023 and bottomed at -$35.8 in Q2 2023.